This article is more than 5 years old. Information may no longer be current.

AbbVie net revenues increase in second quarter

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

AbbVie reported net earnings of $1.983 billion in the second quarter of 2018 compared with net earnings of $1.915 billion in 2017’s first quarter.

The company posted GAAP net revenues of $8.278 billion in the quarter compared with $6.944 billion a year ago, according to a company press release.

Operating expenses increased from $4.3 million in the second quarter of 2017 to $5.5 billion in the second quarter of 2018.

Global sales of Humira (adalimumab) increased 10% for the quarter to $5.185 billion.